Category: NAS

Cancer researcher has dodged accusations for decades (and has a new correction)

Today isn’t a great day for Carlo Croce, chair of the department of cancer biology and genetics at The Ohio State University (OSU).

The New York Times has a lengthy article detailing the misconduct accusations that have swirled around Croce for years. We’ve covered many, but The Gray Lady obtained documents that show there have been many more.

The story mentions a 2013 letter from Ohio State University to pseudonymous whistleblower Clare Francis (which we reported on in 2014), acknowledging Francis’s allegations against Croce. However, in the letter, an administrator said OSU saw no reason to investigate Croce.

The story didn’t stop there, as the Times reports:

Continue reading Cancer researcher has dodged accusations for decades (and has a new correction)

Researchers retract two well-cited papers for misconduct

A scientist in Germany has lost two papers that were collectively cited more than 500 times, after an investigation at her former university found her guilty of scientific misconduct.

The probe into Tina Wenz by the University of Cologne in Germany, her former employer, recommended that six of her papers — which have induced some chatter on PubPeer — should be retracted. One of these papers was pulled by Cell Metabolism last year. Now, Cell Metabolism has pulled another of Wenz’s papers, and she has also lost another study published in the Proceedings of the National Academy of Sciences (PNAS), which was previously corrected. 

First, here’s the PNAS retraction notice, issued today: Continue reading Researchers retract two well-cited papers for misconduct

Authors retract PNAS paper suggesting silk stabilizes vaccines

PNASA PNAS paper that caught the media’s attention for suggesting that adding silk could stabilize vaccines and antibiotics has been pulled after the authors realized there were significant errors in the data analysis. 

According to the notice, the authors agreed to retract the 2012 paper; however, the corresponding author told us the authors did not think a retraction was required as, according to him, the conclusions remained valid.

The paper presented a solution to the long-standing problem that sensitive biological compounds such as vaccines and antibiotics begin to lose their effectiveness outside the recommended temperature range, and naturally biodegrade over time. The degradation process cannot be reversed, and may even speed up during transport or storage under less ideal temperatures.

Here’s the retraction notice: Continue reading Authors retract PNAS paper suggesting silk stabilizes vaccines

Shigeaki Kato up to 38 retractions

Shigeaki Kato
Shigeaki Kato

Our retraction notice count for Shigeaki Kato, number seven on our leaderboard, has grown to 38.

The former University of Tokyo endocrinologist recently earned another retraction, for a paper in Archives of Biochemistry and Biophysics that contained image manipulation. As we’ve noted before, Kato resigned from the university in 2012 as it investigated his work for misconduct; in 2013 a Japanese newspaper reported that the investigation had found 43 papers from his lab contained “likely altered or forged materials.”

In addition to the new retraction, we’ve dug up four others for Kato from the past few years, plus one correction. Two of the retraction notices mention an investigation at the University of Tokyo.

First, the retraction note for “Multiple co-activator complexes support ligand-induced transactivation function of VDR,” published in December:

Continue reading Shigeaki Kato up to 38 retractions

Fast-tracked PNAS papers are cited less often — but gap is shrinking

PNASAn analysis of more than 50,000 papers submitted to Proceedings of the National Academy of Sciences (PNAS) shows that those published using its “contributed track” — in which academy members can fast-track their own papers by coordinating the peer-review process themselves — have been cited less often than regular submissions, but that gap is shrinking.

Although the overall average difference in citations between contributed and regular submissions was 9%, the yearly difference has declined from 13.6% in 2005 to 2.2% in 2014, according to the new study, posted before peer review on the preprint server bioRxiv by Phil Davis, an independent researcher and publishing consultant based in New York.

The contributed track is a long-standing editorial practice of PNAS, which has triggered concerns from some academics that say Continue reading Fast-tracked PNAS papers are cited less often — but gap is shrinking

Stem cell researcher Jacob Hanna’s correction count updated to 10

Jacob Hanna
Jacob Hanna

Thanks to some eagle-eyed readers, we’ve been alerted to some corrections for high profile stem cell scientist Jacob Hanna that we had missed, bringing our count to one retraction and 13 errata on 10 papers.

The problems in the work range from duplications of images, to inadvertent deletions in figures, to failures by his co-authors to disclose funding sources or conflicts of interest. Hanna is the first or last author on 4 of the papers, and one of several on the rest.

First up, a correction to a Cell paper on which Hanna is the first author:

Continue reading Stem cell researcher Jacob Hanna’s correction count updated to 10

First author refuses to sign PNAS retraction after “key findings” are not reproduced

33.cover

Two out of the three authors of a PNAS paper on mutations underlying lung diseases are pulling it after failing to reproduce key findings.

The paper, published in 2012, investigated how mutations in lung surfactant genes induce molecular changes that lead to lung pulmonary fibrosis and lung cancer might work. But follow-up work revealed problems. In the retraction note, last author Christine Kim Garcia and second author Christoper Cano, both at the University of Texas Southwestern Medical Center, write:

Current members of the C.K.G. laboratory are unable to reproduce key findings reported in the paper.

Here’s the retraction note in full:

Continue reading First author refuses to sign PNAS retraction after “key findings” are not reproduced

Voinnet notches second retraction, two more corrections

PNASOlivier Voinnet — a plant researcher who was recently suspended for two years from the Centre national de la recherche scientifique (CNRS) after an investigation by ETH Zurich and CNRS found evidence of misconduct — has issued his second retraction and two more corrections.

PNAS posted the retraction earlier this week for a 2006 article after an inspection of the raw data revealed “errors” in study images. Authors confirmed the issues in some figures and revealed “additional mounting mistakes” in others.

Voinnet has promised to issue retractions and corrections for every study that requires them. These latest notices bring our tally up to nine corrections, two retractions and one Expression of Concern.

Continue reading Voinnet notches second retraction, two more corrections

Second paper for Duke lung researchers expires in a retraction

pnas 3 5 13Scientists at Duke and the National Institutes of Health have retracted a PNAS paper on asthma treatment after realizing the data from two sources didn’t match, and “most primary data” from several experiments were missing.

The mix up seems to have come from the pulmonary function laboratory that tested how well asthmatic patients’ lungs were functioning on an experimental anti-inflammatory therapy. As the authors say in the retraction note: Continue reading Second paper for Duke lung researchers expires in a retraction

Authors retract PNAS Epstein-Barr virus paper for “anomalous and duplicated” figures

pnas 2515PNAS has retracted a paper on the cancer-causing Epstein-Barr virus just two months after publication, in a notice that fingers a now-former graduate student for manipulating figures.

The paper tries to explain how Epstein-Barr virus blocks the immune system’s attempts to destroy it. According to the notice, the three “nonexperimentalist authors” – identified in the paper as two P.I.’s from University of Texas at Austin and one from the University of California, San Francisco – didn’t know the figures “were not reflective of original Northern blot and immunoblot data.”

That leaves UT Austin PhD student Jennifer Cox under the bus. Her LinkedIn says she pursued a PhD from 2010-2015, though it’s unclear if she’s received a degree. Cox’s name is at the top of P.I. Christopher Sullivan’s list of past lab members, and she’s the only one on the page whose name doesn’t hyperlink to additional information, such as a contact.

The school issued a press release about the study that quoted Cox, which has been removed from the UT site but is still available on Science Daily: Continue reading Authors retract PNAS Epstein-Barr virus paper for “anomalous and duplicated” figures